2.29
price up icon11.17%   0.23
after-market 시간 외 거래: 2.18 -0.11 -4.80%
loading
전일 마감가:
$2.06
열려 있는:
$2.04
하루 거래량:
3.35M
Relative Volume:
1.29
시가총액:
$68.16M
수익:
-
순이익/손실:
$-13.08M
주가수익비율:
-5.1857
EPS:
-0.4416
순현금흐름:
-
1주 성능:
+89.26%
1개월 성능:
+30.11%
6개월 성능:
-54.47%
1년 성능:
-43.73%
1일 변동 폭
Value
$2.04
$2.44
1주일 범위
Value
$2.025
$3.10
52주 변동 폭
Value
$1.12
$8.40

Telomir Pharmaceuticals Inc Stock (TELO) Company Profile

Name
명칭
Telomir Pharmaceuticals Inc
Name
전화
786-396-6723
Name
주소
100 SE 2ND ST, MIAMI
Name
직원
5
Name
트위터
Name
다음 수익 날짜
2024-11-11
Name
최신 SEC 제출 서류
Name
TELO's Discussions on Twitter

TELO을(를) 다른 주식과 비교

주식 가격 시가총액 매출 순이익 현금흐름 주당 순 이익
Biotechnology icon
TELO
Telomir Pharmaceuticals Inc
2.29 61.31M 0 -13.08M 0 -0.4416
Biotechnology icon
VRTX
Vertex Pharmaceuticals Inc
472.27 120.73B 11.10B -988.90M -1.26B -3.92
Biotechnology icon
REGN
Regeneron Pharmaceuticals Inc
564.64 61.80B 14.09B 4.50B 2.96B 39.28
Biotechnology icon
ALNY
Alnylam Pharmaceuticals Inc
328.00 42.46B 2.35B -269.70M -75.39M -2.09
Biotechnology icon
ARGX
Argen X Se Adr
591.74 35.22B 2.58B 1.06B -1.28B 16.33
Biotechnology icon
ONC
Beone Medicines Ltd Adr
296.46 31.99B 3.81B -644.79M -669.77M -6.24

Telomir Pharmaceuticals Inc Stock (TELO) Upgrades & Downgrades

날짜 액션 분석자 등급 변경
2025-02-21 개시 Rodman & Renshaw Buy

Telomir Pharmaceuticals Inc 주식(TELO)의 최신 뉴스

pulisher
08:04 AM

When is the best time to buy Telomir Pharmaceuticals Inc. stockSuperior risk-adjusted returns - jammulinksnews.com

08:04 AM
pulisher
05:29 AM

Telomir Pharmaceuticals Reports Telomir-1's Unique Profile Restores Mitochondrial Health While Improving Oxidative Stress Without Promoting Cell Proliferation in Diseased Human Cell Lines Highlighting Potential Relevance to Neurodegenerative Pathway - Reno Gazette Journal

05:29 AM
pulisher
11:09 AM

Telomir Pharmaceuticals stock surges on promising Progeria treatment results - Investing.com

11:09 AM
pulisher
08:18 AM

Telomir-1 shows promise in restoring mitochondrial function By Investing.com - Investing.com South Africa

08:18 AM
pulisher
08:18 AM

Telomir-1 shows promise in restoring mitochondrial function - Investing.com Australia

08:18 AM
pulisher
08:00 AM

Revolutionary Mitochondrial Drug Could Transform Treatment of Alzheimer's, Parkinson's, and ALS - Stock Titan

08:00 AM
pulisher
Jul 23, 2025

Telomir Pharmaceuticals Inc. Stock Analysis and ForecastExceptional trading results - Autocar Professional

Jul 23, 2025
pulisher
Jul 23, 2025

Telomir Pharmaceuticals Inc (NASDAQ: TELO) Stock Sentiment: What’s Wall Street Saying? - Stocksregister

Jul 23, 2025
pulisher
Jul 23, 2025

Telomir Pharmaceuticals Inc (TELO) Stock: A Year of Stock Market Dynamics - investchronicle.com

Jul 23, 2025
pulisher
Jul 22, 2025

What analysts say about Telomir Pharmaceuticals Inc. stockSuperior returns - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

Is Telomir Pharmaceuticals Inc. a good long term investmentRecord-setting profit potential - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What drives Telomir Pharmaceuticals Inc. stock priceDynamic profit opportunities - jammulinksnews.com

Jul 22, 2025
pulisher
Jul 22, 2025

What makes Telomir Pharmaceuticals Inc. stock price move sharplyGrowth Stock Monitor - Newser

Jul 22, 2025
pulisher
Jul 21, 2025

Pre-market Movers: PMN, GCTK, TELO, SRPT... - RTTNews

Jul 21, 2025
pulisher
Jul 19, 2025

Why Is Telomir Pharmaceuticals Stock (TELO) Up 150% Today? - MSN

Jul 19, 2025
pulisher
Jul 18, 2025

Healthcare Stocks Move in Pre-Market Session: Telomir Pharmaceuticals, Mesoblast, and More - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir Demonstrates Telomir-1 Reverses Epigenetic Gene Silencing of STAT1, Restoring Tumor Suppressor in Human Prostate Cancer Cells, Outperforming Chemotherapy and Rapamycin - Lohud

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir Pharmaceuticals Stock Price, Quotes and Forecasts - Benzinga

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir skyrockets on preclinical data backing epigenetic potential of lead asset - FirstWord Pharma

Jul 18, 2025
pulisher
Jul 18, 2025

Dow Falls Over 200 Points; 3M Earnings Top Views - Benzinga

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir Pharma Skyrockets Nearly 139% After-Hours As Cancer Drug Shows Breakthrough Results, Beats Chemo In Human Cell Tests - NewsBreak: Local News & Alerts

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir Pharmaceuticals Skyrockets 150% on Breakthrough Preclinical Cancer Results - MSN

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir Pharmaceuticals: A Disruptive Force in Prostate Cancer Therapy with Epigenetic Innovation - AInvest

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir Pharmaceuticals stock soars after promising cancer treatment data - Investing.com

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir Pharma Jumps In After-Hours Trading After Drug Reverses Damage In Progeria Cells; Retail Eyes Bigger Gains - Stocktwits

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir Pharmaceuticals stock soars after promising cancer treatment data By Investing.com - Investing.com UK

Jul 18, 2025
pulisher
Jul 18, 2025

Cancer Breakthrough Sends Telomir Pharma Stock Exploding 157% - Wall Street Pit

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir-1 shows stronger epigenetic effects than standard drugs in cancer study - Investing.com Australia

Jul 18, 2025
pulisher
Jul 18, 2025

Telomir-1 shows stronger epigenetic effects than standard drugs in cancer study By Investing.com - Investing.com South Africa

Jul 18, 2025
pulisher
Jul 18, 2025

Revolutionary Cancer Treatment Shows 50% Tumor Reduction, Beats Standard Chemotherapy in Clinical Tests - Stock Titan

Jul 18, 2025

Telomir Pharmaceuticals Inc (TELO) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$23.63
price up icon 3.32%
$36.59
price up icon 1.61%
$103.52
price up icon 0.08%
$27.57
price down icon 1.57%
$114.57
price down icon 0.03%
biotechnology ONC
$296.46
price up icon 0.55%
자본화:     |  볼륨(24시간):